サンバイオの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2017/07/06 | 1,523 | 1,545 | 1,495 | 1,509 | -37 | -2.4% | 341,600 |
| 2017/07/05 | 1,505 | 1,546 | 1,470 | 1,546 | +62 | +4.2% | 531,700 |
| 2017/07/04 | 1,576 | 1,598 | 1,480 | 1,484 | -120 | -7.5% | 1,020,600 |
| 2017/07/03 | 1,600 | 1,694 | 1,575 | 1,604 | +201 | +14.3% | 3,534,600 |
| 2017/06/30 | 1,300 | 1,411 | 1,296 | 1,403 | +74 | +5.6% | 391,700 |
| 2017/06/29 | 1,305 | 1,329 | 1,261 | 1,329 | +8 | +0.6% | 203,300 |
| 2017/06/28 | 1,343 | 1,343 | 1,320 | 1,321 | -17 | -1.3% | 88,500 |
| 2017/06/27 | 1,341 | 1,348 | 1,323 | 1,338 | -9 | -0.7% | 96,500 |
| 2017/06/26 | 1,329 | 1,355 | 1,327 | 1,347 | +19 | +1.4% | 128,300 |
| 2017/06/23 | 1,363 | 1,383 | 1,322 | 1,328 | -35 | -2.6% | 209,800 |
| 2017/06/22 | 1,370 | 1,381 | 1,351 | 1,363 | -2 | -0.1% | 148,000 |
| 2017/06/21 | 1,331 | 1,371 | 1,312 | 1,365 | +28 | +2.1% | 284,100 |
| 2017/06/20 | 1,357 | 1,360 | 1,333 | 1,337 | -18 | -1.3% | 202,900 |
| 2017/06/19 | 1,358 | 1,362 | 1,325 | 1,355 | ±0 | ±0% | 210,000 |
| 2017/06/16 | 1,338 | 1,363 | 1,312 | 1,355 | +15 | +1.1% | 253,800 |
| 2017/06/15 | 1,291 | 1,342 | 1,289 | 1,340 | +20 | +1.5% | 319,600 |
| 2017/06/14 | 1,407 | 1,429 | 1,312 | 1,320 | -47 | -3.4% | 1,027,100 |
| 2017/06/13 | 1,252 | 1,367 | 1,235 | 1,367 | +102 | +8.1% | 990,000 |
| 2017/06/12 | 1,232 | 1,280 | 1,225 | 1,265 | +38 | +3.1% | 206,800 |
| 2017/06/09 | 1,200 | 1,227 | 1,197 | 1,227 | +29 | +2.4% | 163,000 |
| 2017/06/08 | 1,201 | 1,215 | 1,197 | 1,198 | -4 | -0.3% | 94,400 |
| 2017/06/07 | 1,197 | 1,208 | 1,195 | 1,202 | -9 | -0.7% | 149,500 |
| 2017/06/06 | 1,260 | 1,260 | 1,211 | 1,211 | -54 | -4.3% | 219,800 |
| 2017/06/05 | 1,261 | 1,279 | 1,260 | 1,265 | -7 | -0.6% | 126,600 |
| 2017/06/02 | 1,271 | 1,278 | 1,260 | 1,272 | +1 | +0.1% | 113,800 |
| 2017/06/01 | 1,280 | 1,290 | 1,270 | 1,271 | -13 | -1% | 51,100 |
| 2017/05/31 | 1,266 | 1,288 | 1,256 | 1,284 | +9 | +0.7% | 114,400 |
| 2017/05/30 | 1,298 | 1,302 | 1,267 | 1,275 | -17 | -1.3% | 111,100 |
| 2017/05/29 | 1,291 | 1,303 | 1,287 | 1,292 | +1 | +0.1% | 69,800 |
| 2017/05/26 | 1,307 | 1,323 | 1,291 | 1,291 | -8 | -0.6% | 254,300 |
| 2017/05/25 | 1,257 | 1,299 | 1,254 | 1,299 | +45 | +3.6% | 197,800 |
| 2017/05/24 | 1,255 | 1,258 | 1,242 | 1,254 | +6 | +0.5% | 86,800 |
| 2017/05/23 | 1,247 | 1,259 | 1,242 | 1,248 | +3 | +0.2% | 103,700 |
| 2017/05/22 | 1,250 | 1,260 | 1,244 | 1,245 | +2 | +0.2% | 51,500 |
| 2017/05/19 | 1,254 | 1,264 | 1,241 | 1,243 | -2 | -0.2% | 133,400 |
| 2017/05/18 | 1,246 | 1,269 | 1,243 | 1,245 | -34 | -2.7% | 118,400 |
| 2017/05/17 | 1,273 | 1,292 | 1,271 | 1,279 | +6 | +0.5% | 112,000 |
| 2017/05/16 | 1,283 | 1,284 | 1,260 | 1,273 | +9 | +0.7% | 88,800 |
| 2017/05/15 | 1,263 | 1,296 | 1,262 | 1,264 | +3 | +0.2% | 118,900 |
| 2017/05/12 | 1,245 | 1,280 | 1,233 | 1,261 | +14 | +1.1% | 124,700 |
| 2017/05/11 | 1,262 | 1,279 | 1,231 | 1,247 | -16 | -1.3% | 132,100 |
| 2017/05/10 | 1,285 | 1,285 | 1,244 | 1,263 | -11 | -0.9% | 132,900 |
| 2017/05/09 | 1,295 | 1,304 | 1,267 | 1,274 | -16 | -1.2% | 171,100 |
| 2017/05/08 | 1,292 | 1,310 | 1,287 | 1,290 | +9 | +0.7% | 346,000 |
| 2017/05/02 | 1,251 | 1,287 | 1,247 | 1,281 | +32 | +2.6% | 316,700 |
| 2017/05/01 | 1,244 | 1,250 | 1,221 | 1,249 | +13 | +1.1% | 198,700 |
| 2017/04/28 | 1,200 | 1,240 | 1,186 | 1,236 | +23 | +1.9% | 165,700 |
| 2017/04/27 | 1,240 | 1,241 | 1,205 | 1,213 | -31 | -2.5% | 147,600 |
| 2017/04/26 | 1,228 | 1,246 | 1,220 | 1,244 | +32 | +2.6% | 289,100 |
| 2017/04/25 | 1,171 | 1,228 | 1,166 | 1,212 | +38 | +3.2% | 265,600 |
1951～
2000
件表示中 / 2501件
類似銘柄と比較する
現在ご覧いただいている「サンバイオ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| サンバイオ | 218,300円 | - | - | 0.00% | - | 101.11倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| 科研薬 | 377,400円 | -6.4% | -71.8% | 5.03% | 42.15倍 | 0.94倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| ジーエヌアイ | 312,500円 | +21.7% | +999.9% | 0.00% | 13.10倍 | 4.34倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 東和薬品 | 293,500円 | +7.9% | -3.3% | 2.73% | 8.16倍 | 0.84倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| ゼリア新薬 | 204,000円 | +3.1% | -6.5% | 2.35% | 9.46倍 | 1.01倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
市場注目の銘柄
チャート関連のコラム
